Navigation Links
Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug
Date:9/3/2009

female with an average age of 58 years, and an average history of OAB duration of more than 9 years.

"PTNS may be considered a clinically significant alternative to pharmacologic therapy for the treatment of OAB with statistically significant improvements in patient self-assessments compared to drugs, and comparable objective effectiveness," said Dr. Kenneth M. Peters, the primary author, and Chairman of the Department of Urology at Beaumont Hospital in Royal Oak, Michigan. "PTNS represents an important addition to our therapeutic armamentarium."

Dr. Peters led the 12-week OrBIT (Overactive Bladder Innovative Therapy) multi-center trial, on which the article "Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial" is based.

The results confirm that Urgent PC's PTNS reduces the incidence of voiding episodes at a rate comparable to extended-release tolterodine, known by the trade name Detrol(R) LA (Pfizer), the leading pharmaceutical therapy for OAB, and that patients report a statistically significant decrease in their overall OAB symptoms compared to patients on extended-release tolterodine.

The study of 100 patients was conducted in 11 U.S. centers. These patients were randomized to either PTNS treatment with Urgent PC, or to extended-release tolterodine. All patients in the study were diagnosed with urinary frequency at eight or more voids per day. Patients randomized into the PTNS treatment were treated weekly for 12 consecutive weeks, while patients randomized into the pharmacologic therapy were given a 90-day prescription of 4 mg daily. All patients completed voiding and bladder control diaries and questionnaires at baseline and after completion of 12 weeks of treatment.


'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Recently Published Study Demonstrates Pharmacokinetic Advantages of ENDOMETRIN(R) Over Crinone(R) for Progesterone Supplementation
2. ANAVEX reports sigma receptor review published in leading journal
3. PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen
4. Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination
5. New Published Diet Study Reveals Meal Replacements as Top Strategy for Weight Loss
6. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
7. Latest Holiday Migraine Survey Results Published
8. Top Dermatologists to be Selected and Published in "The Leading Physicians of the World" Consumer Directory.
9. Human Pheromones: Whats Purported, Whats Supported - A White Paper Published by The Sense of Smell Institute
10. ACC Responds to Study Published in Pediatrics About Phthalate and IV Tubing
11. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... http://www.risperdallawsuit2014.com/ ) have been filed in a ... Bernstein Liebhard LLP reports. , Documents recently ... show 1,079 records included in the state proceeding, ... treat schizophrenia, bipolar disorder and other psychiatric conditions. ...
(Date:11/27/2014)... -- Thanksgiving meals can pose a challenge for people ... says. Many traditional Thanksgiving dishes -- such as ... gluten-free, but "when it comes to pies, stuffing, gravy, ... Anca Safta, director of the Gluten and Allergic Digestive ... North Carolina, said in a center news release. ...
(Date:11/27/2014)... Vegas, NV (PRWEB) November 27, 2014 ... 2014 shopping season has officially launched, Emassagechair.com ... and Cyber Monday Discount Event. , Negotiating on ... relationships with top massage chair brands, Emassagechair.com has generated ... their best deals and biggest discounts yet. , Shoppers ...
(Date:11/27/2014)... 27, 2014 “Wekho” was featured on NewsWatch ... and coolest mobile applications on the iOS, Android, and Windows ... NewsWatch, conducted the app review and shared with ... people. , An interesting new way to travel and experience ... devices. It’s called Wekho and it’s a free geolocation ...
(Date:11/27/2014)... This is a professional and ... For an overview analysis, the report introduces Insulin ... structure, industry overview, policy analysis, and news analysis, ... covers information on policy, plans for Insulin Market ... much more. , This report also ...
Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... Mich., Oct. 17 The State Senate,Committee passed legislation today ... on Michigan roads. In their,latest bid to rid riders of ... solution. For a $100 fee, motorcyclists,can buy their way out ... voted on by the State Senate in the near,future. The ...
... to change cervical cancer screening practices, , , WEDNESDAY, Oct. 17 ... -- which causes most cervical cancers -- was far better ... studies show. , What,s unclear, however, is whether or not ... because it can have a slightly higher false positive rate, ...
... for research into treatment, cure for,devastating lung disease, ... Fibrosis (CPF) announced the passage of important legislation,that ... of idiopathic,pulmonary fibrosis (IPF), a deadly lung disease ... and a diseases which claims 40,000 lives a,year, ...
... SAN FRANCISCO, Oct. 17 Collaborative Drug Discovery,Inc. ... six years of,recent publications focused on the fight ... data are available to researchers free of charge, ... of Medicinal Chemistry, Bioorganic &,Medicinal Chemistry, the Journal ...
... Have Their Dreams Come True ... LAS VEGAS, Oct. 17 The Emerald Dream Team, headed ... National Search,for 12 women who have been diagnosed with breast cancer ... whisked away, with a,guest, to Las Vegas on Dec. 26th, all ...
... and CEDAR KNOLLS, N.J., Oct. 17 ,PainCare ... of the nation,s leading providers,of pain-focused medical ... Inc. (OTC Bulletin Board: MDFI), a company ... today jointly,announced the formation of a partnership ...
Cached Medicine News:Health News:Michigan Senate Committee Votes in Favor of 'Opt-Out' Option for State's Helmet Law; AAA Says Deaths and Injuries Will Increase 2Health News:HPV Test Bests Pap Smear in Studies 2Health News:HPV Test Bests Pap Smear in Studies 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 4Health News:Free Access to Literature Data on Chagas' Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with 'archive mine and collaborate' access to small molecule bioactivity SAR data on parasitic disease 2Health News:The Emerald Dream Ball 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 4Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 5Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 6
(Date:11/26/2014)... Investor-Edge has initiated coverage on the following equities: ... (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... and Theravance Inc. (NASDAQ: THRX ). Free research ... . On Tuesday, November 25, 2014, the NASDAQ ... Average edged 0.02% lower, to finish the day at 17,814.94, ...
(Date:11/26/2014)... RADNOR, Pa. , Nov. 26, 2014 ... dedicated to the development of innovative transdermal synthetic cannabinoid ... the Piper Jaffray 26th Annual Healthcare Conference 2014. The ... the New York Palace in New York ... , will present at 4:50 pm on Tuesday, December ...
(Date:11/26/2014)... NEW YORK and ... the leading distributor of market intelligence, MarketResearch.com is pleased ... by IQ4I Research and Consultancy focusing on the active ... about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Ingredients Global Market – Forecast to 2020 ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Oct. 6 BioTrends Research Group, Inc. recently published ... This report is ... practice in China and qualitative interviews conducted with ten ... of nephrology practice in China and focuses specifically on ...
... (Nasdaq: ARAY ), a global leader in ... patient has been treated with the CyberKnife ® ... the treatment of both cancerous and non-cancerous tumors anywhere ... CyberKnife radiosurgery received treatment during Accuray,s fiscal 2010, which ...
Cached Medicine Technology:New Report by BioTrends Examines the Treatment of Renal Anemia in China 2100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System 2100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System 3
Full automatic, ready-to-use strip washer....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
... an unmatched combination of speed, accuracy and ... assessing and monitoring a patient's A1C levels., ... simple fingerstick and delivers A1C results in ... a proven and time-tested having received full ...
Medicine Products: